Podcasts about reachmd cardiology

CME credits: 0.50 Valid until: 14-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/reducing-morbidity-and-mortality-in-patients-with-ckd-in-t2d-new-late-breaking-data/14165/ The FIDELITY pooled analysis findings demonstrated benefits in cardiovascular and kidney outcomes when nonsteroidal mineralocorticoid receptor antagonists (MRAs) were added to the mix. Tune in to hear Drs. Pam Taub, Gerasimos Filippatos, and George Bakris discuss the risk factors of chronic kidney disease, the importance of measuring eGFR and UACR, and how finerenone improves outcomes.

CME credits: 0.25 Valid until: 07-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/what-you-should-know-when-addressing-gdmt-for-id-in-heart-failure/13509/ Despite being an important and common comorbid condition in patients with heart failure, iron deficiency remains underdiagnosed and undertreated. Join Dr. Piotr Ponikowski, Dr. Andrew Sindone, and Dr. Adrian Hernandez as they discuss using guideline-directed medical therapy to overcome the morbidity, mortality, and very poor quality of life experienced by patients with heart failure and iron deficiency.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Yehuda Handelsman, MD The National Lipid Association (NLA) and the American College of Cardiology (ACC) recently provided recommendations to help us achieve optimal low-density lipoprotein (LDL) levels in statin-intolerant patients, but what other management strategies are available? Joining Dr. Charles Turck to answer this question and to give more key insights is Dr. Yehuda Handelsman, Medical Director and Principal Investigator at the Metabolic Institute of America.

CME credits: 0.25 Valid until: 30-09-2023 Claim your CME credit at https://reachmd.com/programs/cme/what-are-we-missing-iron-deficiency-in-heart-failure/13514/ Iron deficiency in patients with heart failure remains underdiagnosed, undertreated, and commonly overlooked in non-anemic patients and has a significant impact on patient outcomes and quality of life. Join Dr. Robert Mentz and Dr. Peter van der Meer as they discuss approaches to identifying and treating iron deficiency in patients with heart failure and comorbidities such as diabetes.

CME credits: 0.25 Valid until: 15-09-2023 Claim your CME credit at https://reachmd.com/programs/cme/experts-discuss-longevity-and-durability-with-tavr/13997/ Data are limited on the incidence and factors associated with structural valve deterioration (SVD) after transcatheter aortic valve replacement (TAVR) and surgery for severe aortic stenosis in patients of all risk levels. The lifetime management of these patients requires an understanding of bioprosthetic valve durability and failure. Tune in for new evidence evaluating the 5-year incidence, outcomes, and predictors of hemodynamic SVD in patients undergoing TAVR and surgery that will support best practices for treatment selection.

CME credits: 0.50 Valid until: 14-09-2023 Claim your CME credit at https://reachmd.com/programs/cme/improved-patient-outcomes-needed-stat-for-anemia-in-chronic-kidney-disease/14037/ Clinicians have a critical need for up-to-date knowledge related to anemia of CKD. Provide better care for your patients by learning about the importance of assessing and treating while considering the burdens of the disease, advances in our understanding of the pathophysiology of the disease, ways to fill the unmet needs of treatment with ESAs, and the status of potential new therapies. Tune in to keep up!

CME credits: 0.25 Valid until: 09-09-2023 Claim your CME credit at https://reachmd.com/programs/cme/maximally-tolerated-or-suboptimal-therapy-clinical-perspectives-on-rechallenging-raasi-therapy/13262/ In heart failure, the use of MRAs is often delayed despite being a crucial part of medical therapy. The evidence is clear that clinical inertia and the suboptimal use of these therapies leads to poorer outcomes for our patients. Join Dr. Ileana Piña and Dr. Patrick Rossignol as they discuss approaches to the clinical stigma surrounding the use of MRAs, as well as management strategies to better ensure the best medical therapy possible for our patients with heart failure.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Javier Morales, MD, FACP, FACE Out of the 32 million patients with diabetes in the United States, 40 percent also have chronic kidney disease. But what's even more alarming is that only 10 percent of these patients know they have chronic kidney disease. So what strategies can we use to address the unmet needs and barriers faced when managing patients with chronic kidney disease and type 2 diabetes? Joining Dr. Charles Turck to answer this and other key questions is Dr. Javier Morales, Associate Clinical Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell on Long Island.

Guest: Gates B. Colbert, MD, FASN Approximately 34 million patients live with diabetes in the United States, and up to 40 percent of those patients also have chronic kidney disease (CKD). That's why it's so important to know how to identify and prevent CKD progression in patients with diabetes, and here to share key strategies is Dr. Gates Colbert, Assistant Clinical Professor at Texas A&M College of Medicine.

Guest: Mikhail Kosiborod, MD Patients with diabetes-related chronic kidney disease (CKD) are at high risk for a number of adverse events over a relatively short period of time. So what do we have in terms of efficacious therapies that can help make a positive impact in that regard? Here to share what we need to know about non-steroidal mineralocorticoid receptor antagonists (MRAs) for the treatment of diabetes-related CKD is Dr. Mikhail Kosiborod, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke's Mid America Heart Institute.

CME credits: 0.25 Valid until: 26-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/looking-beyond-diabetes-the-role-of-sglt2i-and-mras-in-cardiorenal-disease/13259/ Optimizing GDMT for patients with heart failure and concomitant kidney dysfunction and/or diabetes continues to be a challenge despite the overwhelming clinical evidence and recent updates to the guidelines for heart failure management. Recent evidence from clinical trials with SGLT2 inhibitors and mineralocorticoid receptor antagonists and the use of novel potassium binders provide new therapeutic opportunities for these patients. This activity will review the current challenges in initiating and maintaining patients on optimal RAASi therapy and approaches to improve cardiorenal outcomes.

CME credits: 0.25 Valid until: 19-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/why-ischemia-matters-when-it-comes-to-iron-deficiency-in-heart-failure/13507/ Iron deficiency, independent of anemia status, is common in heart failure and is associated with increased risk for heart failure hospitalization and cardiovascular mortality, reduced functional status, and poor exercise performance. This impact may be magnified in patients with ischemic etiology. Join Dr. Marco Metra and Dr. Piotr Ponikowski as they discuss the clinical relevance of ischemic etiology in the management and outcomes of patients with heart failure and iron deficiency.

CME credits: 0.25 Valid until: 16-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/looking-beyond-diabetes-the-role-of-sglt2i-and-mras-in-cardiorenal-disease/13259/ Optimizing GDMT for patients with heart failure and concomitant kidney dysfunction and/or diabetes continues to be a challenge despite the overwhelming clinical evidence and recent updates to the guidelines for heart failure management. Recent evidence from clinical trials with SGLT2 inhibitors and mineralocorticoid receptor antagonists and the use of novel potassium binders provide new therapeutic opportunities for these patients. This activity will review the current challenges in initiating and maintaining patients on optimal RAASi therapy and approaches to improve cardiorenal outcomes.

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/translating-blood-pressure-lowering-to-reductions-in-end-organ-damage/14220/ tbd

tbd

tbd

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/hypertension-vs-resistant-hypertension-what-are-the-key-differences/14219/ tbd

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/clinical-practice-guidelines-for-resistant-hypertension-what-are-recommendations/14223/ tbd

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/gi-insights/what-does-a-typical-resistant-hypertension-patient-look-like/14222/ tbd

CME credits: 0.50 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/beyond-pulmonary-hypertension-month-diagnosing-treating-pah/13843/ Join Dr. John Russell as he speaks about diagnosing and treating pulmonary arterial hypertension using the latest pharmacologic and medical management strategies with Dr. Valerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan.

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/the-endothelin-et-system-and-its-role-in-resistant-hypertension/14225/ tbd

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/what-new-therapies-drugs-and-devices-are-on-the-horizon-for-resistant-hypertension/14226/ tbd

CME credits: 0.50 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/beyond-pulmonary-hypertension-month-diagnosing-treating-pah/13843/ Join Dr. John Russell as he speaks about diagnosing and treating pulmonary arterial hypertension using the latest pharmacologic and medical management strategies with Dr. Valerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan.

Host: John J. Russell, MD Guest: Vallerie V. Mclaughlin, MD Join Dr. John Russell as he speaks about diagnosing and treating pulmonary arterial hypertension using the latest pharmacologic and medical management strategies with Dr. Valerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan.

CME credits: 1.00 Valid until: 15-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/how-will-the-game-change-with-the-entry-of-new-agentsmoasdifferent-pharmacokinetics-for-resistant-hypertension/14227/ tbd

Host: Hector O. Chapa, MD, FACOG Guest: Erin D. Michos, MD, MHS, FACC, FAHA, FASE Polycystic ovary syndrome (PCOS) affects approximately 5 to 13 percent of women in the general population. And although previous research has shown its link to cardiovascular (CV) risk factors later in life, a new study has revealed that PCOS can increase the risk of heart complications during delivery. So what do these findings mean when it comes to caring for pregnant patients with PCOS? Find out with Dr. Hector Chapa as he's joined by lead author of the study Dr. Erin Michos, who's the Director of Women's Cardiovascular Health and an Associate Professor of Medicine at Johns Hopkins School of Medicine.

Host: Javed Butler, MD, MBA, MPH Guest: Sameed Khatana, MD, MPH As global temperatures continue to rise, experts are calling attention to the devastating effects this can have on human health. Cardiovascular mortality is especially a concern, as two recent studies from the University of Pennsylvania outlined the connection between these two health risks. To learn more about how climate change can impact our cardiovascular health, Dr. Javed Butler is joined by Dr. Sameed Khatana, Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania and a physician at the Philadelphia Veterans Affairs Medical Center.

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/achd-basic-lesion-types/14407/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/summing-up-understudied-ph-populations/14411/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/the-importance-of-referring-the-pah-achd-patient-to-an-accredited-specialty-center/14410/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/management-of-chd-pah-general-considerations/14409/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/imaging-in-achd-pah-what-the-phchd-specialty-center-offers/14408/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/setting-the-stage-what-are-the-understudied-ph-populations/14399/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/a-short-tour-of-congenital-heart-disease-associated-pah-chd-pah/14406/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/the-echocardiogram-is-of-central-importance-to-ctd-pah-diagnosis-and-referral/14404/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/tbd/14403/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/screening-the-ctd-patient-for-development-of-pah-why-must-we-do-this/14402/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/ctd-associated-pah-perspectives-for-rheumatologists-and-pulmonologists-working-together-to-build-clinical-suspicion/14401/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/connective-tissue-diseases-ctd-identifying-patients-with-ph/14400/ tbd

CME credits: 1.00 Valid until: 29-07-2023 Claim your CME credit at https://reachmd.com/programs/cme/tbd/14405/ tbd

Host: Javed Butler, MD, MBA, MPH Guest: Alice White, PhD Guest: Christopher Chen, MD, PhD There is currently no safe way to get a close-up view of the human heart, which is exactly why a team of Boston University researchers created a device to mimic the human organ. So how does the new device called miniPUMP work, and how was it developed? To discuss this, Dr. Javed Butler is joined by Dr. Alice White and Dr. Christopher Chen from Boston University.

Guest: Todd H. Baron, MD What do we need to know about esophageal perforations? Dr. Todd H. Baron from the University of North Carolina School of Medicine shares how he treats patients with esophageal perforations.

Guest: Todd H. Baron, MD What do we need to know about esophageal perforations? Dr. Todd H. Baron from the University of North Carolina School of Medicine shares how he treats patients with esophageal perforations.

CME credits: 1.00 Valid until: 30-06-2023 Claim your CME credit at https://reachmd.com/programs/cme/dyspnea-many-possible-causes-always-to-be-taken-seriously/14182/ TBD

CME credits: 1.00 Valid until: 30-06-2023 Claim your CME credit at https://reachmd.com/programs/cme/summing-up-know-when-unexplained-dyspnea-is-something-really-serious/14191/ TBD

CME credits: 1.00 Valid until: 30-06-2023 Claim your CME credit at https://reachmd.com/programs/cme/how-can-we-make-it-easier-to-develop-that-index-of-suspicion-for-pah/14184/ TBD

CME credits: 1.00 Valid until: 30-06-2023 Claim your CME credit at https://reachmd.com/programs/cme/echocardiography-not-definitive-for-ph-but-essential-to-determine-need-for-referral-to-ph-center/14185/ TBD

CME credits: 1.00 Valid until: 30-06-2023 Claim your CME credit at https://reachmd.com/programs/cme/using-echocardiography-to-get-a-handle-on-heart-structure-and-function-in-ph/14186/ TBD

Host: Javed Butler, MD, MBA, MPH Guest: Tariq Ahmad, MD, MPH The Pragmatic Trial of Messaging to Providers About Treatment in Heart Failure (PROMPT-HF) was designed to test the hypothesis that tailored and targeted electronic health record alerts recommending guideline-directed medical therapy (GDMT) for patients with heart failure (HF) would result in greater adherence to medication use. Explore the trial's findings with Dr. Javed Butler and Dr. Tariq Ahmad, Director of the Heart Transplant and Mechanical Circulatory Support Program and Chief of Heart Failure at the Yale University School of Medicine.

Host: John J. Russell, MD Guest: Joseph E. Bavaria, MD Featuring a wide range of disciplines and a new approach to comprehensive care, what do we need to know about the Aorta Center at Penn Medicine? Dr. John Russell is joined by Dr. Joseph E. Bavaria to dive into this aortic program and discuss a new approach to comprehensive care.